Phase I Study of the Combination of Anlotinib With Gefitinib
Clinical trial NCT03602027 · UNKNOWN
Trial details
- NCT number
- NCT03602027
- Sponsor
- Second Affiliated Hospital of Nanchang University
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-01
- Primary completion
- 2018-12-01
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.